Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
Bio-Rad Laboratories (NYSE: BIO and BIO.B) has announced the appointment of Jon DiVincenzo as President and Chief Operating Officer, effective September 9, 2024. DiVincenzo, who brings over 30 years of industry experience, will replace the retiring Andy Last. He joins Bio-Rad from Labcorp Holdings Inc., where he most recently served as Executive Vice President and President of Central Laboratories and International.
DiVincenzo's extensive background includes leadership roles at PerkinElmer, Enzymatics, and EMD Millipore. His experience spans strategic, operational, and commercial organizations in both life science and clinical diagnostics. Norman Schwartz, Bio-Rad's Chairman and CEO, expressed enthusiasm about DiVincenzo's appointment, highlighting his track record in operations, marketing, and product development as integral to the company's future success.
Bio-Rad Laboratories (NYSE: BIO e BIO.B) ha annunciato la nomina di Jon DiVincenzo a Presidente e Direttore Operativo, con decorrenza dal 9 settembre 2024. DiVincenzo, che porta con sé oltre 30 anni di esperienza nel settore, sostituirà Andy Last, che va in pensione. Proviene da Labcorp Holdings Inc., dove ha recentemente ricoperto il ruolo di Vice Presidente Esecutivo e Presidente dei Laboratori Centrali e Internazionali.
DiVincenzo ha un ampio background che include ruoli di leadership presso PerkinElmer, Enzymatics ed EMD Millipore. La sua esperienza abbraccia organizzazioni strategiche, operative e commerciali sia nel settore delle scienze della vita che nella diagnostica clinica. Norman Schwartz, Presidente e CEO di Bio-Rad, ha espresso entusiasmo per la nomina di DiVincenzo, sottolineando la sua esperienza nelle operazioni, nel marketing e nello sviluppo del prodotto, considerata fondamentale per il future successo dell'azienda.
Bio-Rad Laboratories (NYSE: BIO y BIO.B) ha anunciado el nombramiento de Jon DiVincenzo como Presidente y Director de Operaciones, con efecto el 9 de septiembre de 2024. DiVincenzo, que aporta más de 30 años de experiencia en la industria, reemplazará al jubilado Andy Last. Se une a Bio-Rad desde Labcorp Holdings Inc., donde ocupó recientemente el cargo de Vicepresidente Ejecutivo y Presidente de Laboratorios Centrales e Internacionales.
El extenso historial de DiVincenzo incluye roles de liderazgo en PerkinElmer, Enzymatics y EMD Millipore. Su experiencia abarca organizaciones estratégicas, operativas y comerciales tanto en ciencias de la vida como en diagnósticos clínicos. Norman Schwartz, Presidente y CEO de Bio-Rad, expresó su entusiasmo por el nombramiento de DiVincenzo, destacando su trayectoria en operaciones, marketing y desarrollo de productos como integral para el futuro éxito de la empresa.
바이오레드 실험실(Bio-Rad Laboratories)(NYSE: BIO 및 BIO.B)는 Jon DiVincenzo를 사장 겸 COO로 임명했다고 발표했으며, 2024년 9월 9일에 효력이 발생합니다. 30년 이상의 산업 경험을 가진 DiVincenzo는 은퇴하는 Andy Last를 대신하게 됩니다. 그는 최근 Labcorp Holdings Inc.에서 중앙 실험실 및 국제 담당 부사장으로 재직했습니다.
DiVincenzo는 PerkinElmer, Enzymatics 및 EMD Millipore에서의 리더십 역할을 포함한 광범위한 배경을 가지고 있습니다. 그의 경험은 생명 과학과 임상 진단 모두에서 전략적, 운영적 및 상업 조직을 포괄합니다. 노먼 슈워츠(Bio-Rad의 회장 겸 CEO)는 DiVincenzo의 임명에 대한 열정을 표현하며, 운영, 마케팅 및 제품 개발에서의 그의 경력이 회사의 미래 성공에 필수적이라고 강조했습니다.
Bio-Rad Laboratories (NYSE: BIO et BIO.B) a annoncé la nomination de Jon DiVincenzo en tant que Président et Directeur des Opérations, à compter du 9 septembre 2024. DiVincenzo, qui apporte plus de 30 ans d'expérience dans l'industrie, remplacera Andy Last, en instance de retraite. Il rejoint Bio-Rad en provenance de Labcorp Holdings Inc., où il a récemment occupé le poste de vice-président exécutif et président des laboratoires centraux et internationaux.
Le parcours varié de DiVincenzo comprend des rôles de leadership chez PerkinElmer, Enzymatics et EMD Millipore. Son expérience couvre des organisations stratégiques, opérationnelles et commerciales dans les domaines de la science de la vie et du diagnostic clinique. Norman Schwartz, Président et PDG de Bio-Rad, a exprimé son enthousiasme pour la nomination de DiVincenzo, soulignant que son expérience en matière d'opérations, de marketing et de développement de produits est essentielle pour le succès futur de l'entreprise.
Die Bio-Rad Laboratories (NYSE: BIO und BIO.B) haben die Ernennung von Jon DiVincenzo zum Präsidenten und Chief Operating Officer bekannt gegeben, die am 9. September 2024 in Kraft tritt. DiVincenzo, der über 30 Jahre Branchenerfahrung verfügt, wird den scheidenden Andy Last ersetzen. Er wechselt von Labcorp Holdings Inc., wo er zuletzt als Executive Vice President und Präsident für zentrale Labore und internationale Angelegenheiten tätig war.
DiVincenzos umfangreicher Hintergrund umfasst Führungsrollen bei PerkinElmer, Enzymatics und EMD Millipore. Seine Erfahrung erstreckt sich über strategische, operative und kommerzielle Organisationen im Bereich Lebenwissenschaften und klinische Diagnostik. Norman Schwartz, Vorsitzender und CEO von Bio-Rad, äußerte Begeisterung über DiVincenzos Ernennung und hebt hervor, dass seine Erfolgsbilanz in den Bereichen Betrieb, Marketing und Produktentwicklung entscheidend für den zukünftigen Erfolg des Unternehmens ist.
- Appointment of an experienced industry veteran as President and COO
- New leadership brings expertise in both life science and clinical diagnostics sectors
- Potential for fresh perspectives and strategies to drive company growth
- None.
Mr. DiVincenzo joins Bio-Rad from Labcorp Holdings Inc., a global provider of comprehensive laboratory services, where he held various global operational and commercial leadership roles across the company’s several business units. Most recently, he served as Executive Vice President and President, Central Laboratories and International. Prior to LabCorp, Mr. DiVincenzo was President of the Environmental Health Division at PerkinElmer, a global company focused on diagnostics, life science research, food quality, environmental health and industrial testing. He also served as Chief Executive Officer of Enzymatics, a privately held molecular biology reagents company. Prior to that, Mr. DiVincenzo held roles of increasing responsibility in the Biosciences and Lab Water businesses of EMD Millipore, a subsidiary of Merck KGaA. He holds a Bachelor of Science degree in mechanical engineering from Northeastern University.
"We are thrilled to welcome Jon DiVincenzo as our President and Chief Operating Officer,” stated Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer. “Jon brings to Bio-Rad over thirty years of industry experience across strategic, operational, and commercial organizations in both life science and clinical diagnostics. His extensive track record spans leadership roles in operations, marketing, and product development, which will be integral to our continued success.”
Mr. DiVincenzo stated, "I am excited to join Bio-Rad and I look forward to working with the executive team to continue to make progress towards achieving the company’s long-term transformational and growth objectives.”
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240820682671/en/
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When will Jon DiVincenzo start as President and COO of Bio-Rad (BIO)?
What is Jon DiVincenzo's previous work experience before joining Bio-Rad (BIO)?
Who is Jon DiVincenzo replacing at Bio-Rad (BIO)?
What educational background does Jon DiVincenzo have?
